R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of s

R&D

We knew it was coming, and now it’s close.

R&D

Dr Jay Shah is Chief Medical Officer of Aktiia.

R&D

Sometimes getting a new drug to market is a relatively straight line, but sometimes it’s a winding road.

R&D

Tune in for updates from BIO 2024 in San Diego on Wednesday, June 5th.

R&D

This year’s Veeva R&D and Quality Summit saw full-house attendance at the Marriott Auditorium Hotel in Madrid.